Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Sodium–potassium pump
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Exogenous === The {{chem2|Na+/K+}}-ATPase can be pharmacologically modified by administering drugs exogenously. Its expression can also be modified through hormones such as [[triiodothyronine]], a [[thyroid]] hormone.{{r|Ramnanan}}<ref>{{Cite journal| vauthors = Lin HH, Tang MJ |date= January 1997|title=Thyroid hormone upregulates Na,K-ATPase α and β mRNA in primary cultures of proximal tubule cells |journal=Life Sciences |volume=60 |issue=6 |pages=375–382 |doi=10.1016/S0024-3205(96)00661-3 |pmid= 9031683}}</ref> For instance, {{chem2|Na+/K+}}-ATPase found in the membrane of heart cells is an important target of [[cardiac glycoside]]s (for example [[digoxin]] and [[ouabain]]), [[inotrope|inotropic]] drugs used to improve [[heart]] performance by increasing its force of contraction. Muscle contraction is dependent on a 100- to 10,000-times-higher-than-resting intracellular [[Calcium in biology|{{chem2|Ca^{2+}|}}]] concentration, which is caused by {{chem2|Ca^{2+}|}} release from the muscle cells' sarcoplasmic reticulum. Immediately after muscle contraction, intracellular {{chem2|Ca^{2+}|}} is quickly returned to its normal concentration by a carrier enzyme in the plasma membrane, and a calcium pump in [[sarcoplasmic reticulum]], causing the muscle to relax. According to the Blaustein-hypothesis,<ref name="pmid324293">{{cite journal | vauthors = Blaustein MP | s2cid = 9814212 | title = Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis | journal = The American Journal of Physiology | volume = 232 | issue = 5 | pages = C165-73 | date = May 1977 | pmid = 324293 | doi = 10.1152/ajpcell.1977.232.5.C165 }}</ref> this carrier enzyme ({{chem2|Na+/Ca^{2+}|}} exchanger, NCX) uses the Na gradient generated by the {{chem2|Na+}}-{{chem2|K+}} pump to remove {{chem2|Ca^{2+}|}} from the intracellular space, hence slowing down the {{chem2|Na+}}-{{chem2|K+}} pump results in a permanently elevated {{chem2|Ca^{2+}|}} level in the [[muscle]], which may be the mechanism of the long-term inotropic effect of cardiac glycosides such as digoxin. The problem with this hypothesis is that at pharmacological concentrations of digitalis, less than 5% of Na/K-ATPase molecules – specifically the α2 isoform in heart and arterial smooth muscle (''K''<sub>d</sub> = 32 nM) – are inhibited, not enough to affect the intracellular concentration of {{chem2|Na+}}. However, apart from the population of Na/K-ATPase in the plasma membrane, responsible for ion transport, there is another population in the [[caveolae]] which acts as digitalis receptor and stimulates the [[EGF receptor]].<ref name="pmid18556748">{{cite journal | vauthors = Schoner W, Scheiner-Bobis G | title = Role of endogenous cardiotonic steroids in sodium homeostasis | journal = Nephrology, Dialysis, Transplantation | volume = 23 | issue = 9 | pages = 2723–9 | date = September 2008 | pmid = 18556748 | doi = 10.1093/ndt/gfn325 | doi-access = }}</ref><ref name="pmid20211726">{{cite journal | vauthors = Blaustein MP, Hamlyn JM | title = Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na<sup>+</sup> pump, the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger and TRPC proteins | journal = Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | volume = 1802 | issue = 12 | pages = 1219–29 | date = December 2010 | pmid = 20211726 | pmc = 2909369 | doi = 10.1016/j.bbadis.2010.02.011 }}</ref><ref name="pmid21642827">{{cite journal | vauthors = Fuerstenwerth H | s2cid = 20180376 | title = On the differences between ouabain and digitalis glycosides | journal = American Journal of Therapeutics | volume = 21 | issue = 1 | pages = 35–42 | date = 2014 | pmid = 21642827 | doi = 10.1097/MJT.0b013e318217a609 }}</ref><ref name="pmid25341357">{{cite journal | vauthors = Pavlovic D | title = The role of cardiotonic steroids in the pathogenesis of cardiomyopathy in chronic kidney disease | journal = Nephron Clinical Practice | volume = 128 | issue = 1–2 | pages = 11–21 | date = 2014 | pmid = 25341357 | doi = 10.1159/000363301 | s2cid = 2066801 | doi-access = }}</ref>
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Sodium–potassium pump
(section)
Add topic